Medical News

RSS

Positive results from REVIVE, a phase 3 pivotal study of avanafil announced

VIVUS, Inc. today announced positive results from REVIVE (TA-301), a phase 3 pivotal study evaluating the safety and efficacy of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED), in 646 patients.

18 Nov 2009

Third-quarter 2009 results announced by Tongjitang Chinese Medicines

Tongjitang Chinese Medicines Company, a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced its financial results for the quarter ended September 30, 2009 and the repurchase of ordinary shares in a private transaction.

18 Nov 2009

MU occupational therapy professor says recovery from brain injuries can last a lifetime

Until recently, scientists believed that, following a stroke, a patient had about six months to regain any lost function. After that, patients would be forced to compensate for the lost function by focusing on their remaining abilities. Although this belief has been refuted, a University of Missouri occupational therapy professor believes that the current health system is still not giving patients enough time to recover and underestimating what the human brain can do given the right conditions.

18 Nov 2009

Cymetrix announces a partnership with Montefiore Medical Center

Cymetrix, a leader in providing hospitals and healthcare networks with revenue cycle management solutions, today announced a partnership with Montefiore Medical Center to provide a unique service to reduce ambulatory charity and bad-debt write-offs.

18 Nov 2009

New study explores consumers' choice in health remedies

Alternative health remedies are increasingly important in the health care marketplace. A new study in the Journal of Consumer Research explores how consumers choose among the many available remedies.

18 Nov 2009

Phase 2/3 study results of Genzyme's APB announced

Genzyme Corporation today reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively compared to placebo. However, the APB did not show a significant improvement in phosphate lowering compared to Genzyme’s Renvela® (sevelamer carbonate).

18 Nov 2009

BioLife Solutions announces that it has been granted a Japanese patent

BioLife Solutions, Inc., a leading developer, manufacturer, and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that it has been granted a Japanese patent for an application that includes claims related to protecting cells from injury and death caused by cold temperatures used in biopreservation.

18 Nov 2009

Study: Larger dose of ARBs is more effective in heart failure patients

A larger dose of angiotensin receptor blockers (ARBs) is more effective than a smaller dose in heart failure patients, researchers said at the American Heart Association's Scientific Sessions 2009.

18 Nov 2009

First Edition: November 18, 2009

Mary Agnes Carey writes about what might become of the Children's Health Insurance Program. One of it's staunchest backers, Sen. Jay Rockefeller, D- W.Va., isn't ready to see it swallowed up by a new health insurance marketplace designed by Congress (Kaiser Health News).

18 Nov 2009

Gene that tells embryonic stem cells when to stop producing neurons identified

Researchers from North Carolina State University have identified a gene that tells embryonic stem cells in the brain when to stop producing nerve cells called neurons. The research is a significant advance in understanding the development of the nervous system, which is essential to addressing conditions such as Parkinson's disease, Alzheimer's disease and other neurological disorders.

18 Nov 2009

A fact-based media briefing on bipolar disorder in Nova Scotia

An estimated 26,000 Nova Scotians live with bipolar disorder. Often stigmatized in popular culture, the experience of bipolar disorder varies from one person to the next and almost always has a drastic impact on how individuals think, behave and function.

18 Nov 2009

VINNOVA to provide SEK 3.6 million for Vitrolife’s stem-cell research

Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife’s research project for optimized culture media to enable the clinical use of stem cells. “It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future”, says Magnus Nilsson, Vitrolife’s CEO.

18 Nov 2009

Homecare, an important part of the solution to nation's healthcare crisis

During November -- National Homecare Month -- the American Association for Homecare celebrates the thousands of dedicated professionals who provide cost-effective and consumer-preferred homecare.

18 Nov 2009

Johns Hopkins program reduces need for airway surgery in hard-to-intubate patients

Be prepared, that old Boy Scout motto, is being applied with great success to operating room patients whose anatomy may make it difficult for physicians to help them breathe during surgery, Johns Hopkins researchers report in a new study.

18 Nov 2009

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ Chikungunya virus DNA vaccine induced protective neutralizing antibody responses in a preclinical non-human primate model.

18 Nov 2009

Researchers at the University of Southampton develop new social networking tool

Researchers at the University of Southampton have developed a new social networking tool that users have described as not only improving reflection and awareness of their own well-being, but also raising their interest in others.

18 Nov 2009

IBM led computing team achieves major advances in large-scale cortical simulation

Today at SC 09, the supercomputing conference, IBM announced significant progress toward creating a computer system that simulates and emulates the brain's abilities for sensation, perception, action, interaction and cognition, while rivaling the brain's low power and energy consumption and compact size.

18 Nov 2009

VirWall KBS-1 keyboard sanitizer eradicates bacteria and viruses on computer keyboards

Engineer/pilot/attorney Jon Roberts, PhD, has dozens of inventions to his credit. They include technology that thwarts piracy in movie theatres, gadgets that track important items inadvertently left behind, devices to enhance airport security and even an electronic matchmaker that alerts two nearby individuals with similar interests that they have, indeed, found their match.

18 Nov 2009

New source of information can help prescribers and patients in understanding anticipated side effects of treatments

In clinical trials for cancer, it is standard for clinicians rather than patients to report adverse symptom side effects from treatments, such as nausea and fatigue. At present, patient self-reporting, although important, is not a well studied source of this information.

18 Nov 2009

NBCC: Revised USPSTF guidelines will put screening and its limitations into proper perspective

For over a decade, National Breast Cancer Coalition has held the position that over-emphasis on the importance of breast cancer screening, despite a lack of strong evidence, has been elevated to such a degree that some even equate screening with prevention.

18 Nov 2009